Abstract
We report two Chinese boys with Wiskott-Aldrich syndrome presenting with gastro-intestinal bleeding, eczema and recurrent infection. They had thrombocytopenia and the mean platelet volume was small. Serum IgG and IgA were elevated and lymphocyte proliferation in response to phytohaemagglutinin, concanavalin A and pokeweed mitogen was defective. Despite documented herpes simplex virus type 1 and cytomegalovirus infection in one patient, he did not mount any humoral response. The generation of antibody-secreting cells in response to pokeweed mitogen was markedly defective in a plaque-forming cell assay. Both patients' regulatory T-cell and B-cell functions were defective in this assay. The genetic defect in Wiskott-Aldrich syndrome therefore affects T-cells, B-cells and platelets.
Similar content being viewed by others
Abbreviations
- CMV:
-
cytomegalovirus
- Con A:
-
concanavalin A
- HSV:
-
herpes simplex virus
- PBMC:
-
peripheral blood mononuclear cells
- PFC:
-
plaque-forming cell
- PHA:
-
phytohaemagglutinin
- PWM:
-
pokeweed mitogen
- SAC:
-
Staphylococcus aureus Cowan I
- WAS:
-
Wiskott-Aldrich syndrome
References
Blaese RM, Strober W, Brown RS, Waldmann TA (1968) The Wiskott-Aldrich syndrome: a disorder with a possible defect in antigen processing or recognition. Lancet I:1056–1061
Capsoni F, Acerbi L, Bonora G, Perletti L, Ongari AM, Vanoli M, Zanussi C (1986) Phagocyte function and immunological findings in a Wiskott-Aldrich syndrome long-term suvivor. J Clin Lab Immunol 19:91–97
Corash L, Shafer B, Blease RM (1985) Platelet-associated immunoglobulin platelet size and the effect of splenetomy in the Wiskott-Aldrich syndrome. Blood 65:1439–1443
DeSaint-Basile G, Arveiler B, Fraser NJ, Boyd Y, Craig IW, Griscelli G, Fischer A (1989) Close linkage of hypervariable marker DXS255 to the disease locus of Wiskott-Aldrich syndrome. Lancet II:1319–1320
Fearon ER, Kohn DB, Winkelstein JA, Vogelstein B, Blaese RM (1988) Carrier detection in the Wiskott-Aldrich syndrome. Blood 72:1735–1739
Funderud S, Erikstein B, Asheim HC, Nustad K, Stoke T, Blomhoff HK, Holte H, Smeland EB (1990) Functional properties of CD19+ B lymphocytes positively selected from buffy coats by immunomagnetic separation. Eur J Immunol 20:201–206
Gealy WJ, Dwyer JM, Harley JB (1980) Allelic exclusion of glucose-6-phosphate dehydrogenase in platelets and T lymphocytes from a Wiskott-Aldrich carrier. Lancet I:63–65
Greer WL, Kwong PC, Peacocke M, Ip P, Rubin LA, Siminovitch KA (1989) X-chromosome inactivation in the Wiskott-Aldrich syndrome: a marker for detection of the carrier state and identification of cell lineages expressing the gene defect. Genomics 4:60–67
Greer WL, Mahtani MM, Kwong PC, Rubin LA, Peacocke M, Willard HF, Siminovitch KA (1989). Linkage studies of the Wiskott-Aldrich syndrome: polymorphisms at TIMP and the X chromosome centromere are informative markers for genetic prediction. Hum Genet 83:227–330
Hendriks RW, De Weers M, Mensink RGH, Kraakman MEN, Mollee-Versteegde IFAM, Veerman AJP, Sandkuyl LA, Schuurman RKB (1991) Diagnosis of Wiskott-Aldrich syndrome by analysis of the X chromosome inactivation patterns in maternal leucocyte populations using the hypervariable DXS255 locus. Clin Exp Immunol 84:219–222
Jones BM (1981) Clinical evaluation of B-cell and T-regulator cell function using a protein A haemolytic plaque assay. Clin Exp Immunol 46:196–205
Kersey JH, Shapiro RS, Filipovich AH (1988) Relationship of immunodeficiency to lymphoid malignancy. Pediatr Infect Dis J 7:S10-S12
Lau YL, Shields JG, Levinsky RJ, Callard RE (1989) Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich Syndrome: response to B cell growth and differentiation factors. Clin Exp Immunol 75:190–195
Lau YL, Low LCK, Jones BM, Lawton JWM (1991) Defective neutrophil and lymphocyte function in leucocyte adhesion deficiency. Clin Exp Immunol 85:202–208
Perry GS III, Spector BD, Schuman LM, Mandel JS, Anderson E, McHugh RB, Hanson MR, Fahlstrom SM, Krivit W, Kersey JH (1980) The Wiskott-Aldrich syndrome in the United States and Canada (1892–1979). J Pediatr 97:72–78
Prchal JT, Carroll AJ, Prchal JF, Crist WM, Skalka HW, Gealy WJ, Harley J, Malluh A (1980) Wiskott-Aldrich syndrome: cellular impariments and their implication for carrier detection. Blood 56:1048–1054
Puck JM, Siminovitch KA, Poncz M, Greenberg CR, Rottem M, Conley ME (1990) Atypical presentation of Wiskott-Aldrich syndrome: diagnosis in two unrelated males based on studies of maternal T cell X chromosome inactivation. Blood 75:2369–2374
Remold-O'Donnell E, Rosen FS (1990) Sialophorin (CD43) and the Wiskott-Aldrich syndrome. Immunodeficiency Reviews 2:151–174
Zabay JM, Fontan G, Campos A, Garcia-Rodriguez MC, Pascual-Salcedo D, Bootello A, DeLa Concha EG (1984) Disorders of regulatory T cell function in patients with the Wiskott-Aldrich Syndrome. Clin Exp Immunol 56:23–28
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lau, Y.L., Jones, B.M., Low, L.C.K. et al. Defective B-cell and regulatory T-cell function in Wiskott-Aldrich syndrome. Eur J Pediatr 151, 680–683 (1992). https://doi.org/10.1007/BF01957573
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01957573